background
multipl
sclerosi
ms
chronic
inflammatori
autoimmun
diseas
central
nervou
system
caus
multipl
sclerosi
unknown
sever
evid
associ
genet
basi
diseas
environment
caus
import
associ
viral
infect
develop
ms
clearli
demonstr
virus
strong
impact
innat
immun
cell
particular
myeloid
dendrit
cell
mdc
plasmacytoid
dendrit
cell
pdc
abl
respond
virus
activ
adapt
immun
respons
method
studi
mimic
viral
infect
use
synthet
singlestrand
rna
resiquimod
compar
respons
dc
subset
deriv
healthi
donor
ms
patient
character
express
costimulatori
molecul
dc
surfac
result
found
pdc
ms
patient
express
higher
level
hladr
healthi
donor
moreov
found
blood
cell
ms
patient
healthi
donor
upon
resiquimodstimul
enrich
subpopul
pdc
character
high
amount
costimulatori
molecul
conclus
overal
result
indic
activ
pdc
enhanc
ms
like
due
latent
viral
infect
costimulatori
molecul
express
pdc
could
mediat
protect
respons
viral
trigger
autoimmun
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
common
neurolog
caus
debilit
adult
incid
ms
current
believ
immunemedi
disord
immun
respons
attack
cn
patholog
directli
mediat
autoantigenspecif
cell
crossreact
nonself
protein
bacteria
virus
self
protein
term
molecular
mimicri
propos
possibl
mechan
onset
autoreact
tcell
respons
fact
infecti
etiolog
ms
suspect
long
time
larg
number
virus
dna
virus
epsteinbarr
viru
ebv
human
herpesviru
rna
virus
human
endogen
retrovirus
coronaviru
dendrit
cell
dc
detect
viral
infect
tolllik
receptor
tlr
key
compon
innat
immun
system
activ
dc
may
trigger
autoreact
cell
subsequ
traffick
activ
cell
cn
howev
like
viral
infect
dc
may
also
activ
protect
immun
respons
aim
clear
virus
peripheri
brain
respons
dc
activ
signal
critic
issu
determin
inflammatori
regulatori
role
immun
respons
two
subset
peripher
blood
dc
human
myeloid
mdc
plasmacytoid
pdc
distinct
function
previou
studi
dc
ms
reveal
monocytederiv
dc
patient
produc
higher
level
tumor
necrosi
healthi
subject
line
observ
mdc
obtain
ms
patient
produc
higher
level
respons
agonist
convers
pdc
ms
patient
produc
lower
level
interferon
ifn
compar
healthi
subject
furthermor
shown
upregul
costimulatori
molecul
upon
stimul
significantli
delay
pdc
ms
patient
compar
healthi
donor
ineffici
matur
pdc
observ
last
paper
could
associ
specif
stimulu
inde
impair
express
pdc
ms
patient
could
impair
respons
stimulu
moreov
studi
exhaust
known
microbeactiv
pdc
featur
distinct
cytokineactiv
dc
overal
studi
indic
dc
ms
patient
healthi
donor
respond
differ
activ
stimuli
suggest
better
understand
differ
may
improv
knowledg
mechan
regul
balanc
proinflammatori
antiinflammatori
immun
respons
ms
diseas
studi
hypothes
differenti
activ
dc
respons
viral
infect
ms
compar
healthi
donor
order
mimic
viral
infect
mdc
pdc
select
singlestrand
rna
resiquimod
strong
signal
abl
simultan
induc
activ
subset
dc
pdc
mdc
systemat
compar
ex
vivo
express
costimulatori
molecul
mdc
pdc
ms
patient
healthi
donor
found
stronger
activ
pdc
ms
compar
healthi
donor
respons
resiquimod
could
mechan
defens
acquir
diseas
could
therapeut
amplifi
increas
antivir
respons
ms
order
analyz
activ
dc
ms
patient
healthi
donor
perform
ex
vivo
cultur
peripher
blood
mononuclear
cell
pbmc
blood
ms
patient
healthi
donor
stimul
either
resiquimod
medium
alon
discrimin
mdc
popul
among
pbmc
use
multicolor
flow
cytometri
figur
analyz
activ
use
fluoresc
antibodi
costimulatori
molecul
particular
focus
attent
three
major
costimulatori
molecul
express
dc
surfac
known
activ
cell
hladr
found
activ
marker
increas
resiquimodstimul
mdc
figur
c
obtain
group
individu
compar
unstimul
cell
howev
mdc
ms
patient
express
similar
level
molecul
compar
mdc
healthi
donor
figur
c
similarli
analyz
activ
pdc
use
antibodi
marker
enabl
discrimin
figur
given
induct
purifi
pdc
demonstr
previou
studi
hypothes
overexpress
pdc
ms
patient
involv
stimul
cell
differenti
th
cell
order
test
hypothesi
perform
experi
stimul
purifi
cell
differ
dose
recombin
figur
interestingli
high
dose
induc
product
indic
overexpress
pdc
ms
patient
may
contribut
induct
helper
respons
moreov
recombin
increas
product
cell
obtain
stimul
cell
figur
given
induct
purifi
pdc
demonstr
previou
studi
hypothes
overexpress
pdc
ms
patient
involv
stimul
cell
differenti
th
cell
order
test
hypothesi
perform
experi
stimul
purifi
cell
differ
dose
recombin
figur
interestingli
high
dose
induc
product
indic
overexpress
pdc
ms
patient
may
contribut
induct
helper
respons
moreov
recombin
increas
product
cell
obtain
stimul
cell
figur
activationinduc
pdc
differenti
three
subpopul
recent
identifi
basi
express
immunecheckpoint
molecul
particular
subpopul
express
high
amount
costimulatori
molecul
includ
order
investig
whether
unstimul
resiquimodstimul
pdc
ms
patient
enrich
subpopul
measur
frequenc
within
pbmc
healthi
donor
ms
patient
although
exvivo
express
unstimul
pdc
low
frequenc
subpopul
significantli
higher
figur
b
howev
three
subpopul
increas
significantli
upon
stimul
resiquimod
healthi
donor
ms
patient
figur
b
previous
demonstr
moreov
observ
healthi
donor
frequenc
significantli
higher
compar
subpopul
ms
patient
frequenc
significantli
higher
whose
frequenc
similar
figur
expect
evalu
median
fluoresc
intens
mfi
reflect
frequenc
three
pdc
subpopul
fact
found
signific
induct
marker
pdc
upon
stimul
howev
differ
healthi
donor
ms
patient
detect
figur
activationinduc
pdc
differenti
three
subpopul
recent
identifi
basi
express
immunecheckpoint
molecul
particular
subpopul
express
high
amount
costimulatori
molecul
includ
order
investig
whether
unstimul
resiquimodstimul
pdc
ms
patient
enrich
subpopul
measur
frequenc
within
pbmc
healthi
donor
ms
patient
although
exvivo
express
unstimul
pdc
low
frequenc
subpopul
significantli
higher
figur
b
howev
three
subpopul
increas
significantli
upon
stimul
resiquimod
healthi
donor
ms
patient
figur
b
previous
demonstr
moreov
observ
healthi
donor
frequenc
significantli
higher
compar
subpopul
ms
patient
frequenc
significantli
higher
whose
frequenc
similar
figur
expect
evalu
median
fluoresc
intens
mfi
reflect
frequenc
three
pdc
subpopul
fact
found
signific
induct
marker
pdc
upon
stimul
howev
differ
healthi
donor
ms
patient
detect
figur
result
indic
pdc
ms
patient
differenti
activ
compar
pdc
healthi
donor
respons
singl
strand
rna
mimick
resiquimod
interestingli
mdc
individu
activ
stimulu
behav
similarli
ms
healthi
donor
could
explain
downstream
signal
activ
pdc
mdc
respect
moreov
fast
indirect
signal
pathway
could
also
influenc
pdc
activ
howev
result
suggest
potenti
differenti
induct
cell
immun
respons
induc
pdc
ms
patient
compar
healthi
donor
instanc
known
agonist
induc
lytic
properti
pdc
via
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
whose
express
directli
correl
individu
viral
load
hiv
patient
similarli
pdc
express
granzym
b
mediat
kill
cell
viral
infect
like
hiv
moreov
report
pdc
ms
patient
stimul
resiquimod
cocultur
cell
significantli
induc
secret
cytokin
produc
new
th
profil
call
interestingli
mous
model
demonstr
costimulatori
molecul
found
highli
express
pdc
ms
patient
contribut
polar
found
recombin
induc
amplifi
product
human
cell
indic
interact
pdc
cell
ms
patient
could
respons
induct
observ
ms
patient
costimulatori
molecul
upregul
pdc
ms
patient
hladr
consid
predomin
molecul
deliv
first
second
signal
tcell
activ
thu
result
indic
could
crucial
costimulatori
molecul
determin
fate
immun
respons
gener
pdc
fact
dictat
differ
type
effector
protect
pathogen
cell
accumul
primari
secondari
respons
well
determin
frequenc
memori
cell
gener
ligat
induc
tfh
polar
inflammatori
respons
regulatori
cell
depend
context
although
lymphocyt
identifi
within
activ
lesion
ms
brain
tissu
role
axi
ms
elucid
moreov
signal
mediat
immun
respons
particularli
relev
viral
infect
demonstr
axi
indirectli
promot
cell
prime
augment
cell
help
directli
enhanc
expans
memori
cell
popul
specif
virus
includ
ebv
wide
associ
ms
ms
frequenc
cell
specif
ebv
lytic
latent
antigen
higher
activ
inact
ms
patient
respect
compar
healthi
donor
underli
import
activ
antiebv
respons
ms
line
effect
axi
cell
activ
agonist
therapi
proven
potent
cancer
immunotherapi
enhanc
cell
tumor
infiltr
moreov
analysi
indic
frequenc
pdc
subpopul
blood
ms
patient
differ
significantli
healthi
donor
accord
similar
level
pdc
ms
patient
healthi
donor
howev
subpopul
pdc
associ
autoimmun
diseas
link
pdcderiv
type
interferon
ifn
psoriasi
lupu
erythemat
sle
howev
physiopatholog
ms
differ
sle
psoriasi
fact
major
ms
patient
benefit
therapi
pdc
ms
patient
produc
lower
level
compar
deriv
healthi
donor
serum
level
type
ifn
well
respons
pbmc
type
ifn
ms
lower
compar
sle
patient
studi
highlight
potenti
role
pdc
axi
protect
antivir
respons
ms
mechan
could
contribut
balanc
inflamm
immun
regul
could
therapeut
modul
ms
patient
toward
protect
immun
respons
patient
relapsingremit
rr
ms
inact
state
accord
establish
criteria
enrol
studi
patient
includ
studi
take
immunomodul
immunosuppress
compound
least
month
recruit
approv
ethic
committe
san
camillo
hospit
novemb
written
inform
consent
accord
declar
helsinki
particip
obtain
studi
initi
control
use
blood
ageand
gendermatch
individu
without
inflammatori
degen
diseas
central
peripher
nervou
system
subject
volunt
underw
blood
draw
peripher
blood
mononuclear
cell
pbmc
isol
ficol
gradient
centrifug
ge
healthcar
littl
chalfont
uk
whole
blood
pbmc
cultur
densiti
cellsml
plate
corn
new
york
citi
ny
usa
rpmi
fetal
bovin
serum
fb
presenc
absenc
resiquimod
invivogen
san
diego
ca
usa
ngml
hour
c
cell
collect
stain
specif
antibodi
discrimin
viabl
pdc
mdc
evalu
express
activ
marker
isol
cell
stain
specif
antibodi
enabl
discrimin
mdc
pdc
pbmc
stain
miltenyi
lymphocyt
purifi
immunomagnet
select
use
antifitc
isol
kit
miltenyi
bergisch
gladbach
germani
isol
cell
stain
fitc
miltenyi
bd
bioscienc
san
jose
ca
usa
pe
bd
bioscienc
apc
miltenyi
naiv
tcell
sort
moflo
high
speed
cell
sorter
beckman
coulter
atlanta
ga
usa
high
high
sort
cell
puriti
measur
flow
cytometri
data
shown
naiv
tcell
cultur
roundbottom
plate
corn
densiti
per
well
xvivo
serumfre
medium
lonza
walkersvil
md
usa
presenc
dynabead
tcell
expand
one
bead
per
cell
life
technolog
carlsbad
ca
usa
ngml
ngml
miltenyi
rnd
minneapoli
mn
usa
use
stimul
cell
day
supernat
collect
quantif
cultur
supernat
measur
elisa
life
technolog
accord
manufactur
instruct
pairwis
comparison
differ
condit
donor
differ
donor
use
nonparametr
twotail
pair
unpair
ttest
respect
data
present
mean
standard
error
sem
p
valu
p
less
consid
statist
signific
author
contribut
mc
gr
perform
research
analyz
data
sr
cg
provid
sampl
ms
patient
lb
contribut
research
design
ev
design
research
analyz
data
wrote
paper
